Abaloparatide approval to enhance osteoporosis treatment landscape for high-risk patients in UK:… EP News Bureau Aug 30, 2024 NICE approves abaloparatide for high-risk osteoporosis patients in the UK, expanding treatment options and reflecting a shift…
